MS Activists' work throughout the year resulted in significant increases for MS funding priorities. These increases include:
- $16 million for the MS Research Program at the Department of Defense - an over $10 million increase from FY 2019.
- $6.1 million to the Lifespan Respite program - an over $2 million increase from FY 2019. These grants to states maximize existing resources and better coordinate and deliver quality respite services to family caregivers.
- $41.7 billion to the National Institutes of Health to fund biomedical research - a $2.6 billion increase from FY 2019.
These bills also included other important priorities benefiting people living with and affected by MS:
- The Patient Centered Outcomes Research Institute (PCORI) is reauthorized until 2029. PCORI has funded approximately $70 million in MS research to help determine what treatments work best for whom, under what circumstances.
- The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 (CREATES) Act was signed into law, which makes it easier for generic drug companies to obtain samples of brand-named products needed to create generics.
- A temporary (five month) re-authorization of two Medicaid demonstration programs that would otherwise expire:
- The Money Follows the Person Program which helps people get the Home & Community-based Services in the setting of their choice, and
- The Spousal Impoverishment Program, which protects a portion of a couples’ income and assets for the needs of the “well spouse” that would otherwise be used to pay for the nursing home care of the other spouse.
- Manual complex wheelchair exemption from the Medicare competitive bidding process that protects access to this important equipment.
To find out more about the Society’s advocacy priorities, please click here.
information source: https://www.nationalmssociety.org/About-the-Society/News/Key-MS-Policy-Priorities-Funded-for-FY-2020